NO176799C - DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid - Google Patents
DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptidInfo
- Publication number
- NO176799C NO176799C NO875378A NO875378A NO176799C NO 176799 C NO176799 C NO 176799C NO 875378 A NO875378 A NO 875378A NO 875378 A NO875378 A NO 875378A NO 176799 C NO176799 C NO 176799C
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- encodes
- express
- producing
- dna encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO19940495A NO315003B1 (no) | 1986-12-23 | 1994-02-14 | Fremgangsmåte for fremstilling av polypeptid samt DNA-sekvens som koder fordette |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30679986 | 1986-12-23 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO875378D0 NO875378D0 (no) | 1987-12-22 |
NO875378L NO875378L (no) | 1988-06-24 |
NO176799B NO176799B (no) | 1995-02-20 |
NO176799C true NO176799C (no) | 1995-05-31 |
Family
ID=17961392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO875378A NO176799C (no) | 1986-12-23 | 1987-12-22 | DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0272703B2 (es) |
JP (1) | JPH068317B2 (es) |
KR (1) | KR960016560B1 (es) |
CA (1) | CA1341522C (es) |
DE (1) | DE3786767T3 (es) |
DK (1) | DK174044B1 (es) |
ES (1) | ES2059354T5 (es) |
HK (1) | HK164195A (es) |
NO (1) | NO176799C (es) |
PT (1) | PT86465B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US5298603A (en) * | 1985-12-21 | 1994-03-29 | Hoechst Aktiengesellschaft | GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use |
GB9107846D0 (en) * | 1990-04-30 | 1991-05-29 | Ici Plc | Polypeptides |
DE4014750A1 (de) * | 1990-05-08 | 1991-11-14 | Boehringer Mannheim Gmbh | Muteine des granulozyten-stimulierenden faktors (g-csf) |
US5688768A (en) | 1991-02-19 | 1997-11-18 | Cor Therapeutics, Inc. | Recombinant thrombin receptor and related pharmaceuticals |
US7119182B1 (en) | 1991-02-19 | 2006-10-10 | The Regents Of The University Of California | Recombinant thrombin receptor and related pharmaceuticals |
US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
HU217872B (hu) | 1994-02-23 | 2000-04-28 | Kyowa Hakko Kogyo Co., Ltd. | Polipeptid alkalmazása vérlemezke termelődést elősegítő gyógyszer előállítására |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US6100070A (en) * | 1995-10-05 | 2000-08-08 | G. D. Searle & Co. | G-CSF receptor agonists |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
DE19860801A1 (de) * | 1998-12-30 | 2000-07-06 | Rhein Biotech Proz & Prod Gmbh | Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor) |
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
JP2004524005A (ja) | 2000-09-08 | 2004-08-12 | マサチューセッツ インスティテュート オブ テクノロジー | G−csfアナログ組成物および方法 |
US7392141B2 (en) | 2001-02-06 | 2008-06-24 | Merck Patent Gmbh | Method of preparing a modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
EP1998266A3 (en) | 2001-02-19 | 2009-02-11 | Merck Patent GmbH | Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
AU2002325819B2 (en) | 2001-07-11 | 2008-06-19 | Maxygen, Inc. | G-CSF Conjugates |
WO2003078461A1 (en) | 2002-03-20 | 2003-09-25 | Biopolymed Inc. | Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
EP1541585B1 (en) | 2002-08-27 | 2013-01-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist and use thereof |
US7785601B2 (en) * | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7695723B2 (en) * | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
CA2517310C (en) | 2003-02-28 | 2015-11-24 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations comprising a poloxamer |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
EP1817047B1 (en) | 2004-11-05 | 2012-02-08 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
KR20080027291A (ko) | 2005-06-01 | 2008-03-26 | 맥시겐 홀딩스 엘티디 | 피이지화된 지-씨에스에프 폴리펩타이드 및 그 제조방법 |
WO2008075371A2 (en) | 2006-12-21 | 2008-06-26 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for immunomodulation |
CA2697265A1 (en) | 2007-08-09 | 2009-02-19 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
US8758761B2 (en) | 2007-09-30 | 2014-06-24 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
WO2010146578A2 (en) | 2009-06-14 | 2010-12-23 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
EP2525787B1 (en) | 2010-01-19 | 2017-03-15 | Hanmi Science Co., Ltd. | Liquid formulations for long-acting g-csf conjugate |
CN102906108B (zh) | 2010-03-04 | 2016-01-20 | 菲尼克斯公司 | 用于无变性制备可溶性重组干扰素蛋白的方法 |
PL2552949T3 (pl) | 2010-04-01 | 2017-01-31 | Pfenex Inc. | Sposoby wytwarzania G-CSF w komórce gospodarza Pseudomonas |
EP2841084B1 (en) | 2012-04-24 | 2018-05-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer |
EP3943098A3 (en) | 2015-07-16 | 2022-05-11 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
KR102033920B1 (ko) | 2016-02-23 | 2019-10-18 | 바이오라인알엑스 리미티드 | 급성 골수성 백혈병을 치료하는 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4869987A (es) | 1971-12-27 | 1973-09-22 | ||
JPS58110600A (ja) | 1981-12-25 | 1983-07-01 | Kyowa Hakko Kogyo Co Ltd | ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド |
JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
EP0215126B1 (en) * | 1985-02-08 | 1991-07-31 | Chugai Seiyaku Kabushiki Kaisha | Human granulocyte colony stimulating factor |
US4810643A (en) | 1985-08-23 | 1989-03-07 | Kirin- Amgen Inc. | Production of pluripotent granulocyte colony-stimulating factor |
DE3681551D1 (de) * | 1985-09-30 | 1991-10-24 | Chugai Pharmaceutical Co Ltd | Menschlicher granulozyten-colony stimulierender faktor. |
EP0256843A1 (en) | 1986-08-11 | 1988-02-24 | Cetus Corporation | Expression of g-csf and muteins thereof and their use |
JP2581110B2 (ja) * | 1987-10-26 | 1997-02-12 | いすゞ自動車株式会社 | パティキュレートトラップの再燃焼装置 |
-
1987
- 1987-12-22 NO NO875378A patent/NO176799C/no not_active IP Right Cessation
- 1987-12-22 DK DK198706809A patent/DK174044B1/da not_active IP Right Cessation
- 1987-12-23 KR KR1019870014791A patent/KR960016560B1/ko not_active IP Right Cessation
- 1987-12-23 JP JP62326384A patent/JPH068317B2/ja not_active Expired - Lifetime
- 1987-12-23 CA CA000555332A patent/CA1341522C/en not_active Expired - Lifetime
- 1987-12-23 EP EP87119157A patent/EP0272703B2/en not_active Expired - Lifetime
- 1987-12-23 PT PT86465A patent/PT86465B/pt unknown
- 1987-12-23 ES ES87119157T patent/ES2059354T5/es not_active Expired - Lifetime
- 1987-12-23 DE DE3786767T patent/DE3786767T3/de not_active Expired - Lifetime
-
1995
- 1995-10-19 HK HK164195A patent/HK164195A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS63267292A (ja) | 1988-11-04 |
JPH068317B2 (ja) | 1994-02-02 |
DE3786767T3 (de) | 1998-04-16 |
NO875378L (no) | 1988-06-24 |
EP0272703B1 (en) | 1993-07-28 |
NO176799B (no) | 1995-02-20 |
DK680987A (da) | 1988-06-24 |
ES2059354T5 (es) | 1998-03-16 |
DK174044B1 (da) | 2002-05-06 |
PT86465A (en) | 1988-01-01 |
HK164195A (en) | 1995-10-27 |
DE3786767T2 (de) | 1994-01-13 |
DK680987D0 (da) | 1987-12-22 |
CA1341522C (en) | 2007-03-13 |
PT86465B (pt) | 1990-11-20 |
KR880007734A (ko) | 1988-08-29 |
KR960016560B1 (ko) | 1996-12-14 |
DE3786767D1 (de) | 1993-09-02 |
ES2059354T3 (es) | 1994-11-16 |
NO875378D0 (no) | 1987-12-22 |
EP0272703B2 (en) | 1997-10-15 |
EP0272703A1 (en) | 1988-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO176799C (no) | DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid | |
ZA822855B (en) | Bacillus cloning vectors,recombinant dna molecules,bacillus hosts transformed with them and methods for expressing foreign dna sequences and producing polypeptides coded thereby | |
DK597288D0 (da) | Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf | |
KR880701557A (ko) | 변형인자 ⅷ:c 및 변형인자ⅷ:c-유사 폴리펠티드를 코오딩하는 dna서열 및 이들 폴리펩티드를 고수율로 제조하는 방법 | |
ES8703490A1 (es) | Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano | |
NO871025D0 (no) | Polypeptid, dna og fremgangsmaate for fremstilling derav. | |
DK217889A (da) | Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for desacetoxycephalosporin c synthetase | |
NO882385L (no) | Polypeptid og produksjon derav. | |
NO845132L (no) | Humant interferon-ypsilon-polypeptidderivat, fremgangsmaate for fremstilling derav og rekombinant plasmid inneholdende et dna-fragment som koder for polypeptidet | |
FI841288A (fi) | Rekombinant-dna-kod foer uttryckning av polypeptid. | |
HUT58107A (en) | Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins | |
DK606088D0 (da) | Rekombinant-dna-udtrykkelsesvektorer og dna-forbindelser, der koder for isopenicillin n synthetase | |
DK160945C (da) | Humant interferon-gamma-polypeptid og fremgangsmaade til fremstilling deraf, rekombinant plasmid omfattende et dna-fragment, som koder for peptidet, og mikroorganisme transformeret med plasmidet | |
DK196188A (da) | Fremgangsmaade til fremstilling af et polypeptid, der kan kodes for genetisk, og anvendelse heraf | |
DK375487A (da) | Rekombinant-pseudorabiesvirus, dets anvendelse til proteinproduktion og saaledes fremstillede produkter | |
EP0149241A3 (en) | Dna base sequence containing regions involved in the production and secretion of a protein, recombinant dna including the whole or a part of the dna base sequence, and method of producing proteins by use of the recombinant dna | |
DE3886517D1 (de) | Menschlicher Prourokinase ähnliches Polypeptid. | |
NO882227D0 (no) | Episomal vektor for ekspresjon av utvalgte dna-fragmenter som koder for polypeptider i pattedyrceller og fremgangsmaate til fremstilling av vektorene. | |
DK447083D0 (da) | Dna, som koder for humant interferon-gamma, rekombinant-dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmade til fremstilling af humant interferon-gamma-polypeptid | |
DK244988D0 (da) | Fremgangsmaade til fremstilling af et polypeptid, der kan kodes for genetisk | |
DK580188D0 (da) | Ekskpressionsplasmid, e.coli-vaertscelle og okse-somatotropin-lignende polypeptid | |
NO179373C (no) | Rekombinant vektor istand til å uttrykke et glykoprotein, transformant som uttrykker et glykoprotein og fremgangsmåte for fremstilling av et glykoprotein | |
NZ224869A (en) | Recombinant plasmids coding for the htv coat protein (gag encoded proteins) and vaccines containing these proteins | |
DK130290D0 (da) | Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner | |
DK397885D0 (da) | Antiviralt og antiproliferativt polypeptid, deoxynucleotidsekvens, som koder derfor, samt dets anvendelse i et recombinant dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |